InterMune Inc. (NASDAQ: ITMN) 67.4% HIGHER; A panel meeting of the Food and Drug Administration resulted in a recommendation for approval of a proposed lung drug from Intermune. The stock has been upgraded at Wells Fargo and ThinkEquity this morning.

Facet Biotech (Nasdaq: FACT) 66.4% HIGHER; Abbott (NYSE: ABT) to buy Facet for $27/share; deal valued at $450 million. Click here for the full report.

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) 44.2% HIGHER; today announced that it has received new 510(k) clearance from the U.S. FDA for new dermatology indications for Microcyn Skin and Wound HydroGel. The Rx